Prudential Financial Inc G1 Therapeutics, Inc. Transaction History

Prudential Financial Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$2.2 - $4.98 $10,648 - $24,103	4,840 Added 31.03%	20,440 $46,000
Q1 2024 May 14, 2024	SELL	$2.1 - $4.83 $5,880 - $13,524	-2,800 Reduced 15.22%	15,600 $67,000
Q4 2023 Feb 13, 2024	SELL	$1.12 - $3.73 $2,912 - $9,698	-2,600 Reduced 12.38%	18,400 $56,000
Q3 2023 Nov 13, 2023	BUY	$1.22 - $2.67 $5,856 - $12,816	4,800 Added 29.63%	21,000 $30,000
Q2 2023 Aug 11, 2023	BUY	$2.46 - $3.14 $39,852 - $50,868	16,200 New	16,200 $40,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.